Citadel Advisors’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.61M | Buy |
|
|||||
|
2025
Q1 | $5.6M | Sell |
|
|||||
|
2024
Q4 | $11M | Buy |
|
|||||
|
2024
Q3 | $9.69M | Sell |
|
|||||
|
2024
Q2 | $9.07M | Buy |
|
|||||
|
2024
Q1 | $7.38M | Sell |
|
|||||
|
2023
Q4 | $34.2M | Sell |
|
|||||
|
2023
Q3 | $32.5M | Buy |
|
|||||
|
2023
Q2 | $5.8M | Sell |
|
|||||
|
2023
Q1 | $18.1M | Buy |
|
|||||
|
2022
Q4 | $17.3M | Buy |
|
|||||
|
2022
Q3 | $397K | Sell |
|
|||||
|
2022
Q2 | $429K | Sell |
|
|||||
|
2022
Q1 | $1.24M | Sell |
|
|||||
|
2021
Q4 | $2.11M | Buy |
|
|||||
|
2021
Q3 | $1.47M | Sell |
|
|||||
|
2021
Q2 | $1.85M | Sell |
|
|||||
|
2021
Q1 | $8.99M | Sell |
|
|||||
|
2020
Q4 | $35.5M | Buy |
|
|||||
|
2020
Q3 | $24.7M | Buy |
|
|||||
|
2020
Q2 | $5.2M | Buy |
|
|||||
|
2020
Q1 | $276K | Buy |
|